Deep sequencing in library selection projects: what insight does it bring?
- PMID: 26451649
- PMCID: PMC4648538
- DOI: 10.1016/j.sbi.2015.09.001
Deep sequencing in library selection projects: what insight does it bring?
Abstract
High throughput sequencing is poised to change all aspects of the way antibodies and other binders are discovered and engineered. Millions of available sequence reads provide an unprecedented sampling depth able to guide the design and construction of effective, high quality naïve libraries containing tens of billions of unique molecules. Furthermore, during selections, high throughput sequencing enables quantitative tracing of enriched clones and position-specific guidance to amino acid variation under positive selection during antibody engineering. Successful application of the technologies relies on specific PCR reagent design, correct sequencing platform selection, and effective use of computational tools and statistical measures to remove error, identify antibodies, estimate diversity, and extract signatures of selection from the clone down to individual structural positions. Here we review these considerations and discuss some of the remaining challenges to the widespread adoption of the technology.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Jacob Glanville is the CSO and co-founder of Distributed Bio, a company that provides the AbGenesis antibody repertoire analysis package as a commercial service.
Figures
References
-
- Ostermeier C, Iwata S, Ludwig B, Michel H. Fv fragment-mediated crystallization of the membrane protein bacterial cytochrome c oxidase. Nat Struct Biol. 1995;2:842–846. One of the first examples of the use of recombinant antibodies as crystallization chaperones. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
